These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6846378)

  • 1. Pharmacologic therapy for the hyperlipidemic patient.
    Hunninghake DB
    Am J Med; 1983 May; 74(5A):19-22. PubMed ID: 6846378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary recommendations for evaluating and treating hyperlipidemia.
    Perry RS
    Clin Pharm; 1986 Feb; 5(2):113-27. PubMed ID: 3514084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1985 Aug; 27(695):74-6. PubMed ID: 3860714
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational drug therapy of the hyperlipoproteinemias, Part II.
    Blum CB; Levy RI
    Ration Drug Ther; 1986 Oct; 20(10):1-4. PubMed ID: 3472266
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
    O'Connor PJ; Rush WA; Trence DL
    J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diet and drug therapy of hyperlipoproteinemia].
    Sirtori C
    Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinic acid in the treatment of hyperlipidaemia.
    Drexel H
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():5-6. PubMed ID: 18001312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on the use of niacin in the treatment of lipid disorders.
    McKenney J
    Arch Intern Med; 2004 Apr; 164(7):697-705. PubMed ID: 15078639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin for lipid disorders. Indications, effectiveness, and safety.
    Brown WV
    Postgrad Med; 1995 Aug; 98(2):185-9, 192-3. PubMed ID: 7630846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipid-lowering drugs. Therapeutics and adverse effects].
    Vogelberg KH
    Med Klin; 1979 Aug; 74(32-33):1171-8. PubMed ID: 224293
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K; Witanowska A
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in pharmacologic treatment of hyperlipidemia.
    Crouse JR; Ryu JE; Kahl FR
    Am J Prev Med; 1989; 5(2):90-4. PubMed ID: 2730796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic drugs.
    Fleischmajer R
    Am Fam Physician; 1978 Feb; 17(2):188-90. PubMed ID: 622945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.